Australia's Control Bionics extends gains to second session on distribution deal
30/01/2026 03:40
** Shares of Control Bionics CBL.AX extends Thursday's gain to as much as 6.8% to A$0.063 ** On Thursday, medical device co said it signed deal with PRC-Saltillo (PRC), stock rose as much as 8.8% ** Under deal, PRC will distribute co's NeuroNode tech in U.S. market ** Stock down 8.7% this week ** Stock has risen 1.6% in 2026, including session's gains (Reporting by Roshan Thomas in Bengaluru) ((Roshan.Thomas@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device